OBI Pharma Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Pembroke VCT PLC Announces Issue of Ordinary Shares
Pembroke VCT PLC announced that the Company has raised a total of GBP11.1 million under the Offer, including additional applications received in respect of the 2013/2014 tax year. An initial allotment of shares took place on April 5, 2013 in respect of 7,916,000 Ordinary Shares and a further allotment took place on April 8, 2013 in respect of 1,155,000 Ordinary Shares, both such allotments having been made pursuant to the Offer. The Offer price at which the Ordinary Shares were allotted was 100 pence per share. Dealings are expected to commence on or around April 16, 2013.
Latest Key Developments in Biotechnology
- Tekmira Pharmaceuticals Corp announces proposed public offering of common stock
- La Jolla Pharmaceutical Co reports positive, top-line results from phase 2 clinical trial of gcs-100 in chronic kidney disease
- FDA designates Regado Biosciences Inc's REG1 in PCI as a fast track development program
- Omeros Corporation announces positive OMS721 Data in Serum from patients with aHUS
- Share this
- Digg this